Linked Life Data

20393175

Source:http://linkedlifedata.com/resource/pubmed/id/20393175

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2010-4-15
pubmed:databankReference
pubmed:abstractText
The comparative efficacy and safety of infliximab and azathioprine therapy alone or in combination for Crohn's disease are unknown.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
2010 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
15
pubmed:volume
362
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1383-95
pubmed:dateRevised
2010-12-10
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Infliximab, azathioprine, or combination therapy for Crohn's disease.
pubmed:affiliation
Hôpital Claude Huriez and Centre d'Investigation Clinique, Centre Hospitalier Universitaire de Lille, Université Lille Nord de France, Lille, France. jfcolombel@chru-lille.fr
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study